First non-repeat cytology test within 12 months prior to diagnosis for young women with cervical cancer for symptomatic cytology tests, and all cytology tests
| Symptomatic cytologya | All cytology tests | |||||
|---|---|---|---|---|---|---|
| Women aged 22–29 years diagnosed from Nov 2010 to Mar 2012 (in-depth study) | Women aged 20–24.5 years diagnosedfrom 4 Nov 2010 to Jul 2014 (national audit) | Women aged 20–29 years diagnosed from Apr 2007 to Jul 2014 (national audit) | ||||
| n | % | n | % | n | % | |
| Negative | 0 | – | 0 | – | 38 | 1.8 |
| Inadequate | – | – | – | – | 22 | 1.0 |
| Borderline low risk | 2 | 9.1 | 0 | – | 59 | 2.8 |
| Mild dyskaryosis | 0 | – | 1 | 3.8 | 68 | 3.2 |
| Borderline high risk | 1 | 4.5 | 2 | 7.7 | 107 | 5.0 |
| Moderate dyskaryosis | 1 | 4.5 | 1 | 3.8 | 187 | 8.8 |
| Severe dyskaryosis | 11 | 50.0 | 8 | 30.8 | 1185 | 55.8 |
| ?Glandular neoplasia | 0 | – | 4 | 15.4 | 175 | 8.2 |
| High-grade dyskaryosis ?invasive | 7 | 31.8 | 10 | 38.5 | 282 | 13.3 |
| Total | 22 | 100 | 26 | 100 | 2123 | 100 |
| High gradeb | 20 | 90.9 | 25 | 96.2 | 1936 | 91.2 |
| Very high gradec | 18 | 81.8 | 22 | 84.6 | 1642 | 77.3 |
↵a Women in the in-depth study had documented symptoms at the time of cytology. Those in the audit were presumed to be symptomatic at cytology, based on their age and the period examined.
↵b High grade, defined as borderline high risk, or moderate dyskaryosis or worse.
↵c Very high grade, defined as severe dyskaryosis or worse. Note: women from the in-depth study should also be included in the audit data because of the overlap in the period examined, but the cytology result used may not be the same.